1.Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1 Rising Prevalence of Cancer
4.1.2 Increasing Adoption of Biologicals and Biosimilars
4.1.3 Huge Impact from Pharmaceutical Industry
4.2 Restraints
4.2.1 Fierce Competition between the Active Pharmaceutical Ingredients (API) (API) Manufacturers
4.2.2 Drug Price Control Policies across Various Countries
4.2.3 Stringent Regulations
4.3 Opportunities
4.3.1 Emerging Technologies
4.3.2 Emerging Markets
4.3.3 Increasing Scope for High-Potency Active Pharmaceutical Ingredients
4.3.4 Emerging Biosimilars Market
4.4 Challenges
4.4.1 High Manufacturing Costs
4.4.2 Product Differentiation
5. Europe Active Pharmaceutical Ingredients Market - By Business Mode
5.1 Captive Active Pharmaceutical Ingredients (API)
5.2 Merchant Active Pharmaceutical Ingredients (API)
6. Europe Active Pharmaceutical Ingredients Market-By Type of Synthesis
6.1 Synthetic
6.2 Biotech
7. Europe Active Pharmaceutical Ingredients Market-By Customer Base
7.1 Generic
7.2 Branded
8. Europe Active Pharmaceutical Ingredients Market - By Application
8.1 Cardiology
8.2 Pulmonology
8.3 Oncology
8.4 Ophthalmology
8.5 Neurology
8.6 Orthopedics
9. Europe Active Pharmaceutical Ingredients Market - By Country
9.1.Introduction
9.2. UK
9.3. Germany
9.4. Italy
9.5 Spain
9.6 Rest of Europe
10. Company Profiles
10.1 Virbac
10.2 Ceva Animal Health, Inc.
10.3 Heska Co.
10.4 Bioniche Animal Health
10.5 Bayer Healthcare
10.6 Boehringer Ingelheim
10.7 Elanco Animal Health
10.8 Merial Inc.
10.9 Merck Animal Health
10.10 Zoetis
11. Europe Active Pharmaceutical Ingredients Market - Competitive Landscape
11.1 Market Share Analysis
11.2 Strategies Adopted by top companies
11.3 Mergers, Acquisitions, Collaborations & Agreements
12. Market Insights
12.1 Insights of Industry Experts
12.2 Investment Opportunities
12.3 Analyst Opinion
13. Appendix
13.1 List of Tables
13.2 List of Figures
